Literature DB >> 11059992

Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus.

P F Liddle1, C J Lane, E T Ngan.   

Abstract

BACKGROUND: Functional imaging studies indicate that delusions and hallucinations in schizophrenia are associated with overactivity of the left hippocampus and ventral striatum. Hippocampal neuronal firing modulates feedback to cortex via cortico-striato-thalamic loops. AIMS: To test the hypothesis that recovery from psychosis is associated with decrease in activity in cortico-striato-thalamic circuits, and, furthermore, that reduction in hippocampal activity predicts the degree of alleviation of delusions and hallucinations.
METHOD: Positron emission tomography (PET) was used to measure the effects of the atypical antipsychotic, risperidone, on glucose metabolism in eight first-episode schizophrenia patients.
RESULTS: A single dose of risperidone produced decreases in metabolism in ventral striatum, thalamus and frontal cortex. The magnitude of decreases in left hippocampus predicted subsequent reduction in delusions and hallucinations. After six weeks' treatment with risperidone, the decreases in frontal metabolism were more extensive.
CONCLUSIONS: The mechanism of antipsychotic action of risperidone entails reduction of hippocampal activity together with reduced feedback via cortico-striato-thalamic loops.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059992     DOI: 10.1192/bjp.177.5.402

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  29 in total

1.  Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.

Authors:  Carol J Lane; Elton T C Ngan; Lakshmi N Yatham; Tom J Ruth; Peter F Liddle
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

Review 2.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 3.  Imaging genomics and response to treatment with antipsychotics in schizophrenia.

Authors:  Giuseppe Blasi; Alessandro Bertolino
Journal:  NeuroRx       Date:  2006-01

4.  Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination.

Authors:  Daniel Bergé; Susanna Carmona; Purificación Salgado; Mariana Rovira; Antoni Bulbena; Oscar Vilarroya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-21       Impact factor: 5.270

5.  Paradoxical sleep as a tool for understanding the hippocampal mechanisms of contextual memory.

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2009-12-11

6.  Progressive paranoid psychosis in a 20-year-old with central congenital hypoventilation syndrome.

Authors:  Alex Dranovsky; Joshua P Needleman; Jessica Sylvester; Ronald VanHeertum; Philip R Muskin
Journal:  Pediatrics       Date:  2014-08-04       Impact factor: 7.124

7.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.

Authors:  M Soyka; W Koch; H J Möller; T Rüther; K Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-18       Impact factor: 5.270

8.  The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations.

Authors:  A Amad; A Cachia; P Gorwood; D Pins; C Delmaire; B Rolland; M Mondino; P Thomas; R Jardri
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

Review 9.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

10.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.